Cyclica Inc. is awarded access to IBM’s Blue Gene supercomputer to repurpose FDA approved drugs

TORONTO, Canada – July 2, 2013 – Cyclica Inc. has been awarded access to IBM’s Blue Gene supercomputer to optimize drug discovery and development using existing drugs that have been identified as having repurposing potential. The project will leverage Cyclica’s data platform, as well as some simulation software packages developed by Modecular. Cyclica’s co-founder, Mickaël… Continue reading Cyclica Inc. is awarded access to IBM’s Blue Gene supercomputer to repurpose FDA approved drugs

Sherbrooke International Life Sciences Summit

  Sherbrooke International Life Sciences Summit (SILS), September 26th & 27th 2013. A unique chance to develop business partnerships with large pharmaceutical and medical technologies businesses! Register now! Regular Rate | Early Bird: $450 CDN Academic Rate (students & researchers) | Early Bird: $350 CDN *Early bird rate ends April 30th 2013 » Schedule now online: http://sils-sherbrooke.com/en/schedule SILS… Continue reading Sherbrooke International Life Sciences Summit

Grand Challenges Canada: Vote for ViroCarb’s Life-Saving Medicine against HIV

Funded by the Government of Canada, Grand Challenges Canada is dedicated to supporting bold ideas with big impact in global health. The Challenge Massive inequalities in health exist across the globe because of persistent global health challenges. Historically, some of the greatest impacts in global health were from innovators who tried out bold ideas. The… Continue reading Grand Challenges Canada: Vote for ViroCarb’s Life-Saving Medicine against HIV

First Step to Pan-Canadian Approach to Management of Drug Costs

By: Richard Y. Cheung and Ingrid VanderElst | Toronto On January 18, 2013, the Canadian provinces and territories (with the exception of Quebec) announced a joint initiative (PDF) designed to achieve significant cost savings for publicly funded drug plans. Working through the Council of the Federation, participating provinces and territories will leverage their combined bargaining… Continue reading First Step to Pan-Canadian Approach to Management of Drug Costs

Social Media in Biotech and Healthcare

By Jeremy Grushcow Use of social media by pharmaceutical companies, biotechs, and industry observers will continue to grow in scale, value and importance this year. The emergence of Twitter as a public health surveillance tool and the pending (still pending…) release of the FDA’s social media guidelines will contribute to this growth in the short term, and… Continue reading Social Media in Biotech and Healthcare